Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation

[1]  Paul F. Meeh,et al.  Characterization of the γδ T cell response to acute leukemia , 2006, Cancer Immunology, Immunotherapy.

[2]  L. Lamb,et al.  γδ T cells: A new frontier for immunotherapy? , 2005 .

[3]  S. Singhal,et al.  Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients , 2004, Bone Marrow Transplantation.

[4]  P. Reimer,et al.  Gammadelta T cells for immune therapy of patients with lymphoid malignancies. , 2003, Blood.

[5]  M. Provinciali,et al.  Reduced number and impaired function of circulating γδ T cells in patients with cutaneous primary melanoma , 2003 .

[6]  R. Soiffer,et al.  The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. , 2001, Blood.

[7]  S. Slavin,et al.  Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes , 2001, Bone Marrow Transplantation.

[8]  Julia M. Lewis,et al.  Regulation of Cutaneous Malignancy by γδ T Cells , 2001, Science.

[9]  P. Henslee-Downey,et al.  Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response , 2001, Bone Marrow Transplantation.

[10]  K. Schilbach,et al.  Human γδ T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells , 2000 .

[11]  J. Klein,et al.  Adoptively Transferred γδ T Cells Indirectly Regulate Murine Graft-Versus-Host Reactivity Following Donor Leukocyte Infusion Therapy in Mice1 , 2000, The Journal of Immunology.

[12]  M. Wilhelm,et al.  Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma , 2000 .

[13]  P. Henslee-Downey,et al.  Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcome. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  W. Drobyski,et al.  Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  J. Connors,et al.  Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[17]  T. Spies,et al.  Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB , 1999 .

[18]  M. Sykes,et al.  Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[19]  T. Spies,et al.  Diversification, expression, and γδ T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules , 1998 .

[20]  T. Imir,et al.  Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis. , 1998, Journal of immunology.

[21]  F. Locatelli.  The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukaemia relapsing following allogeneic transplantation , 1998, British journal of haematology.

[22]  S. Bauer,et al.  Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. , 1998, Science.

[23]  M. Horowitz,et al.  Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation , 1997, Bone Marrow Transplantation.

[24]  P. Henslee-Downey,et al.  Use of partially mismatched related donors extends access to allogeneic marrow transplant. , 1997, Blood.

[25]  E. Holler,et al.  Adoptive immunotherapy with donor lymphocyte transfusions. , 1997, Current opinion in oncology.

[26]  W. Havran,et al.  An innate view of gamma delta T cells. , 1997, Current opinion in immunology.

[27]  Robert H. Collins,et al.  Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  W. Havran,et al.  An innate view of γδ T cells , 1997 .

[29]  K. Parker,et al.  Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. , 1996, Blood.

[30]  A. Gee,et al.  Rapid Communication: Increased Frequency of TCRγδ+ T Cells in Disease-Free Survivors Following T Cell-Depleted, Partially Mismatched, Related Donor Bone Marrow Transplantation for Leukemia , 1996 .

[31]  M. Trigg,et al.  Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. , 1996, Blood.

[32]  A. Barrett,et al.  GRAFT‐VERSUS‐LEUKAEMIA: UNDERSTANDING AND USING THE ALLOIMMUNE RESPONSE TO TREAT HAEMATOLOGICAL MALIGNANCIES , 1996, British journal of haematology.

[33]  J. Bluestone,et al.  Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens. , 1996, Blood.

[34]  R. Krance,et al.  Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors. , 1996, Bone marrow transplantation.

[35]  M. Cooper,et al.  γδ T cells are secondary participants in acute graft‐versus‐host reactions initiated by CD4+ αβT cells , 1996 .

[36]  R. Truitt,et al.  Principles of graft-vs.-leukemia reactivity. , 1995, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[37]  M. Hessner,et al.  Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. , 1995, Blood.

[38]  G. Macdonald,et al.  Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality. , 1995, Journal of immunology.

[39]  A Ferrant,et al.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.

[40]  P. Rohrlich,et al.  Potential antileukemic effect of gamma delta T cells in acute lymphoblastic leukemia. , 1995, Leukemia.

[41]  M. Ferrarini,et al.  Daudi lymphoma killing triggers the programmed death of cytotoxic V gamma 9/V delta 2 T lymphocytes. , 1995, Journal of immunology.

[42]  S. Kato,et al.  Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation. , 1994, Bone marrow transplantation.

[43]  L. Glimcher,et al.  Most gamma delta T cells develop normally in the absence of MHC class II molecules. , 1993, Journal of immunology.

[44]  J. Antin.  Graft-versus-leukemia: no longer an epiphenomenon (editorial) , 1993 .

[45]  P. Cruz,et al.  Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. , 1993, Cancer research.

[46]  H. Sinn,et al.  ROLE OF NATURAL KILLER CELLS IN THE PATHOGENESIS OF HUMAN ACUTE GRAFT‐VERSUS‐HOST DISEASE , 1993, Transplantation.

[47]  S. Ferrini,et al.  TCR gamma/delta positive lymphocytes after allogeneic bone marrow transplantation. , 1992, Bone marrow transplantation.

[48]  J. Sloane,et al.  An immunohistological study of gamma/delta lymphocytes in human cutaneous graft-versus-host disease. , 1991, Bone marrow transplantation.

[49]  A. Rimm,et al.  Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.

[50]  L. Degos,et al.  TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells , 1989 .

[51]  R Storb,et al.  Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. , 1989, Blood.

[52]  G. Heller,et al.  Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts , 1989 .

[53]  W. Gregory,et al.  Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effect , 1988, British journal of haematology.

[54]  R. Hoffmann,et al.  Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. , 1988 .

[55]  T. Ghayur,et al.  Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. , 1987, Transplantation.

[56]  T. Ghayur,et al.  KINETICS OF NATURAL KILLER CELLCYTOTOXICITY REACTION: Relationship Between Natural Killer Cell Activity, T and B Cell Activity, and Development of Histopathological Alterations , 1987 .

[57]  L. Lamb,et al.  gammadelta T cells: a new frontier for immunotherapy? , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[58]  M. Provinciali,et al.  Reduced number and impaired function of circulating gamma delta T cells in patients with cutaneous primary melanoma. , 2003, The Journal of investigative dermatology.

[59]  C. Figdor,et al.  TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells. , 2001, Bone marrow transplantation.

[60]  F. van Rhee,et al.  Human gammadelta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response. , 2001, Bone marrow transplantation.

[61]  A. Hayday,et al.  Regulation of cutaneous malignancy by gammadelta T cells. , 2001, Science.

[62]  J. Klein,et al.  Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice. , 2000, Journal of immunology.

[63]  H. Tony,et al.  Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. , 2000, Blood.

[64]  K. Schilbach,et al.  Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells. , 2000, Journal of immunotherapy.

[65]  D. Porter,et al.  The graft-versus-leukemia effects of allogeneic cell therapy. , 1999, Annual review of medicine.

[66]  S. Bauer,et al.  Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  A. Gee,et al.  Influence of T cell depletion method on circulating γδ T cell reconstitution and potential role in the graft-versus-leukemia effect , 1999 .

[68]  J. Goldman,et al.  Adoptive immunotherapy following allogeneic bone marrow transplantation. , 1998, Annual review of medicine.

[69]  V. Groh,et al.  Diversification, expression, and gamma delta T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Cooper,et al.  Gamma delta T cells are secondary participants in acute graft-versus-host reactions initiated by CD4+ alpha beta T cells. , 1996, European journal of immunology.

[71]  P. Henslee-Downey,et al.  Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation. , 1994, Progress in clinical and biological research.

[72]  J. Antin.  Graft-versus-leukemia: no longer an epiphenomenon. , 1993, Blood.

[73]  M. Potter,et al.  Immune reconstitution after BMT in children. , 1993, Bone marrow transplantation.

[74]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .